circulating tumor DNA
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech
The company, founded by Stanford University scientists, is advancing a technology called PhasED-Seq for cancer minimal residual disease detection.
The company expects to launch testing for advanced cancer patients this year, with studies now running to expand to cancer screening and monitoring applications.
Sutter Health Exploring In-House ctDNA Testing in Effort to Expand Precision Oncology Access
Premium
The California health system is working with Canexia to assess if a triaged, in-house testing strategy improves outcomes, lowers cost, and reduces access inequities.
Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer
The study will recruit 200 non-small cell lung cancer patients, comparing results of the company's ctDNA testing to tissue next-generation sequencing.
Apr 15, 2021
Mar 18, 2021
Mar 11, 2021
Burning Rock Q4 Revenues Rise 50 Percent
Mar 4, 2021
Feb 24, 2021
Guardant Health Q4 Revenues Up 25 Percent
Feb 23, 2021